BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keighley MRB. Gastrointestinal cancers in Europe: GASTROINTESTINAL CANCERS IN EUROPE. Alimentary Pharmacology & Therapeutics 2003;18:7-30. [DOI: 10.1046/j.0953-0673.2003.01722.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hung CS, Wang YC, Guo JW, Yang RN, Lee CL, Shen MH, Huang CC, Huang CJ, Yang JY, Liu CY. Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer. Mol Med Rep 2020;21:659-66. [PMID: 31974611 DOI: 10.3892/mmr.2019.10871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
3 Shin HJ, Moon HS, Kang SH, Sung JK, Jeong HY, Kim SH, Lee BS, Kim JS, Yun GY. Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma: Is it a significant prognostic factor? Medicine (Baltimore) 2017;96:e9441. [PMID: 29390576 DOI: 10.1097/MD.0000000000009441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Zoltan L, Farkas R, Schally AV, Pozsgai E, Papp A, Bognár L, Tornoczki T, Mangel L, Bellyei S. Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer. Pathol Oncol Res 2019;25:279-88. [PMID: 29103201 DOI: 10.1007/s12253-017-0342-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Giganti F, Ambrosi A, Petrone MC, Canevari C, Chiari D, Salerno A, Arcidiacono PG, Nicoletti R, Albarello L, Mazza E, Gallivanone F, Gianolli L, Orsenigo E, Esposito A, Staudacher C, Del Maschio A, De Cobelli F. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study. Br J Radiol 2016;89:20160087. [PMID: 27767330 DOI: 10.1259/bjr.20160087] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
6 Abudu EK, Akinbami OS. Colorectal Carcinomas in Uyo City, Southern Geopolitical Zone of Nigeria: A Review of Clinicopathological Characteristics and Literature. Rare Tumors 2016;8:6175. [PMID: 27441074 DOI: 10.4081/rt.2016.6175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Hejna M, Wöll E, Tschandl P, Raderer M. Cutaneous paraneoplastic disorders in stomach cancer: Collaboration between oncologically active dermatologists and clinical oncologists. Crit Rev Oncol Hematol 2016;103:78-85. [PMID: 27247117 DOI: 10.1016/j.critrevonc.2016.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
8 Boursi B, Mamtani R, Hwang WT, Haynes K, Yang YX. A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results. Dig Dis Sci 2016;61:2076-86. [PMID: 26894401 DOI: 10.1007/s10620-016-4081-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Giganti F, Salerno A, Ambrosi A, Chiari D, Orsenigo E, Esposito A, Albarello L, Mazza E, Staudacher C, Del Maschio A, De Cobelli F. Prognostic utility of diffusion-weighted MRI in oesophageal cancer: Is apparent diffusion coefficient a potential marker of tumour aggressiveness? Radiol Med. 2016;121:173-180. [PMID: 26392393 DOI: 10.1007/s11547-015-0585-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
10 Arezzo A, Matsuda T, Rembacken B, Miles WF, Coccia G, Saito Y. Piecemeal mucosectomy, submucosal dissection or transanal microsurgery for large colorectal neoplasm. Colorectal Dis 2015;17 Suppl 1:44-51. [PMID: 25511861 DOI: 10.1111/codi.12821] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Freire P, Figueiredo P, Cardoso R, Donato MM, Sá A, Portela F, Romãozinho JM, Sofia C. Card15 mutations and gastric cancer in a Portuguese population. Scand J Gastroenterol 2013;48:1188-97. [PMID: 24047397 DOI: 10.3109/00365521.2013.832370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Vera P, Dubray B, Palie O, Buvat I, Hapdey S, Modzelewski R, Benyoucef A, Rousseau C, Meyer ME, Bardet S, Gardin I, Fiore FD, Michel P. Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer. EJNMMI Res 2014;4:12. [PMID: 24602385 DOI: 10.1186/2191-219X-4-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
13 Di Fiore A, Lecleire S, Gangloff A, Rigal O, Benyoucef A, Blondin V, Sefrioui D, Quiesse M, Iwanicki-caron I, Michel P, Di Fiore F. Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer. Digestive and Liver Disease 2014;46:270-5. [DOI: 10.1016/j.dld.2013.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
14 Zhu CL, Huang Q, Liu CH, Lin XS, Xie F. Prognostic value of HIF-1α expression in patients with gastric cancer. Mol Biol Rep. 2013;40:6055-6062. [PMID: 24057269 DOI: 10.1007/s11033-013-2715-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
15 Hu QD, Zhang Q, Chen W, Bai XL, Liang TB. Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers. World J Gastroenterol 2013; 19(32): 5261-5270 [PMID: 23983428 DOI: 10.3748/wjg.v19.i32.5261] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
16 Palie O, Michel P, Ménard JF, Rousseau C, Rio E, Bridji B, Benyoucef A, Meyer ME, Jalali K, Bardet S, M'vondo CM, Olivier P, Faure G, Itti E, Diana C, Houzard C, Mornex F, Di Fiore F, Vera P. The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imaging 2013;40:1345-55. [PMID: 23715903 DOI: 10.1007/s00259-013-2450-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
17 Duong HQ, Hwang JS, Kim HJ, Seong YS, Bae I. BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells. Int J Oncol 2012;41:2227-36. [PMID: 23076030 DOI: 10.3892/ijo.2012.1672] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
18 Papp A, Cseke L, Varga G, Pavlovics G, Potó L, Márton S, Farkas R, Bellyei S, Horváth ÖP. A neoadjuváns kezelés szerepe a nyaki szakaszon elhelyezkedő előrehaladott nyelőcsőlaphámrákok sebészi kezelésében. MaSeb 2012;65:340-7. [DOI: 10.1556/maseb.65.2012.5.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Meyer HJ, Wilke H. Treatment strategies in gastric cancer. Dtsch Arztebl Int. 2011;108:698-705; quiz 706. [PMID: 22114638 DOI: 10.3238/arztebl.2011.0698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 36] [Article Influence: 0.3] [Reference Citation Analysis]
20 Duong HQ, Kim HJ, Kang HJ, Seong YS, Bae I. ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. Oncol Rep 2012;27:182-8. [PMID: 21993922 DOI: 10.3892/or.2011.1503] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
21 Sandi MJ, Hamidi T, Malicet C, Cano C, Loncle C, Pierres A, Dagorn JC, Iovanna JL. p8 Expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis. J Cell Physiol 2011;226:3442-51. [DOI: 10.1002/jcp.22702] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
22 Gimeno-garcía A, Quintero E, Nicolás-pérez D, Jiménez-sosa A. Public awareness of colorectal cancer and screening in a Spanish population. Public Health 2011;125:609-15. [DOI: 10.1016/j.puhe.2011.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
23 Beyazit Y, Koklu S, Ozturk ZA, Yüksel O, Ibis M, Arhan M, Gultuna S, Sezer S, Yuksel I, Babali A. Inclusion of a Spasmolytic in Bowel Cleansing: A Prospective Randomized Study. Gastroenterology Nursing 2011;34:352-5. [DOI: 10.1097/sga.0b013e318229bc90] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Wahba HA, El-Hadaad HA, Abd-Ellatif EA. Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer. Med Oncol 2012;29:1693-8. [PMID: 21706368 DOI: 10.1007/s12032-011-0001-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
25 Buri L, Zullo A, Hassan C, Bersani G, Anti M, Bianco MA, Cipolletta L, Giulio ED, Matteo GD, Familiari L, Ficano L, Loriga P, Morini S, Pietropaolo V, Zambelli A, Grossi E, Tessari F, Intraligi M, Buscema M; and the SIED Appropriateness Working Group. Upper GI endoscopy in elderly patients: predictive factors of relevant endoscopic findings. Intern Emerg Med 2013;8:141-6. [DOI: 10.1007/s11739-011-0598-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Brown M, Sillah K, Griffiths EA, Swindell R, West CM, Page RD, Welch IM, Pritchard SA. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology. 2010;56:893-899. [PMID: 20636792 DOI: 10.1111/j.1365-2559.2010.03559.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
27 Ladabaum U, Ferrandez A, Lanas A. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev. 2010;19:2765-2776. [PMID: 20810603 DOI: 10.1158/1055-9965.epi-10-0530] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
28 Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45:703-712. [PMID: 20157748 DOI: 10.1007/s00535-010-0214-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
29 Gimeno-garcía AZ, Quintero E, Nicolás-pérez D, Parra-blanco A, Jiménez A. Colorectal cancer screening in a Spanish population. Medicina Clínica 2009;133:736-40. [DOI: 10.1016/j.medcli.2009.03.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
30 Papp A, Cseke L, Farkas R, Pavlovics G, Horvath G, Varga G, Szigeti A, Bellyei S, Marton S, Poto L, Kalmar K, Vereczkei A, Pozsgai E, Horvath OP. Chemo-radiotherapy in Locally Advanced Squamous Cell Oesophageal Cancer—are Upper Third Tumours more Responsive? Pathol Oncol Res 2010;16:193-200. [DOI: 10.1007/s12253-009-9206-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
31 Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Parra-Blanco A, Jiménez-Sosa A. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study. Cancer Epidemiol 2009;33:216-22. [PMID: 19747893 DOI: 10.1016/j.canep.2009.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
32 Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br J Cancer. 2009;101:1155-1161. [PMID: 19738614 DOI: 10.1038/sj.bjc.6605285] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
33 Wang W, Adachi M, Zhang R, Zhou J, Zhu D. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Pancreas 2009;38:e114-23. [PMID: 19342982 DOI: 10.1097/MPA.0b013e3181a0b6f2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
34 Andreu García M, Marzo M, Mascort J, Quintero E, García-Alfonso P, López-Ibor C, Castells A, Segura PP; Alianza para la Prevención del Cáncer de Colon en España. [Prevention of colorectal cancer]. Aten Primaria 2009;41:127-8. [PMID: 19304348 DOI: 10.1016/j.aprim.2008.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Andreu García M, Marzo M, Mascort J, Quintero E, García-alfonso P, López-ibor C, Castells A, Pérez Segura P. Prevención del cáncer colorrectal. Gastroenterología y Hepatología 2009;32:137-9. [DOI: 10.1016/j.gastrohep.2008.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Andreu M, Marzo M, Mascort J, Quintero E, García-alfonso P, López-ibor C, Castells T, Segura PP. Colorectal cancer prevention. Clin Transl Oncol 2009;11:65-6. [DOI: 10.1007/s12094-009-0314-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Voutilainen M. Epidemiological trends in oesophageal cancer in the Nordic countries. Scand J Gastroenterol. 2008;43:323-327. [PMID: 18938769 DOI: 10.1080/17489530701699720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Ladas SD. Ethical issues in the management of elderly patients in gastroenterology and digestive endoscopy. Expert Rev Gastroenterol Hepatol 2007;1:257-63. [PMID: 19072418 DOI: 10.1586/17474124.1.2.257] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Liu WS, Yan HJ, Qin RY, Tian R, Wang M, Jiang JX, Shen M, Shi CJ. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity. Dig Dis Sci 2009;54:89-96. [PMID: 18594980 DOI: 10.1007/s10620-008-0329-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
40 Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-63. [PMID: 17680847 DOI: 10.1111/j.1572-0241.2007.01437.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 7.7] [Reference Citation Analysis]
41 Papp A, Cseke L, Pavlovics G, Farkas R, Varga G, Márton S, Pótó L, Esik O, Horváth OP. [The effect of preoperative chemo-radiotherapy in the treatment of locally advanced squamous cell carcinoma in the upper- and middle-thirds of the esophagus]. Magy Seb 2007;60:123-9. [PMID: 17727214 DOI: 10.1556/MaSeb.60.2007.3.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
42 Quintero E, Parra-blanco A. Noninvasive diagnostic tools in colorectal cancer mass screening. Curr colorectal cancer rep 2007;3:29-34. [DOI: 10.1007/s11888-007-0013-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Kumar Y, Tapuria N, Kirmani N, Davidson BR. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. Eur J Gastroenterol Hepatol. 2007;19:265-276. [PMID: 17301655 DOI: 10.1097/meg.0b013e3280102f78] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
44 Griffiths EA, Pritchard SA, McGrath SM, Valentine HR, Price PM, Welch IM, West CM. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer. 2007;96:1377-1383. [PMID: 17437013 DOI: 10.1038/sj.bjc.6603744] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
45 Okamoto K, Ocker M, Neureiter D, Dietze O, Zopf S, Hahn EG, Herold C. bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells. J Cell Mol Med 2007;11:349-61. [PMID: 17378914 DOI: 10.1111/j.1582-4934.2007.00013.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
46 Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ. Chemoprevention for colon cancer: new opportunities, fact or fiction? Scand J Gastroenterol Suppl. 2006;158-164. [PMID: 16782636 DOI: 10.1080/00365520600664284] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
47 Michel P, Adenis A, Di Fiore F, Boucher E, Galais MP, Dahan L, Mirabel X, Hamidou H, Raoul JL, Jacob JH. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer. 2006;95:705-709. [PMID: 16967056 DOI: 10.1038/sj.bjc.6603328] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
48 Yona D, Arber N. Coxibs and cancer prevention. J Cardiovasc Pharmacol 2006;47 Suppl 1:S76-81. [PMID: 16785835 DOI: 10.1097/00005344-200605001-00014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
49 Bitoun A, Ponchon T, Barthet M, Coffin B, Dugué C, Halphen M. Results of a prospective randomised multicentre controlled trial comparing a new 2-L ascorbic acid plus polyethylene glycol and electrolyte solution vs. sodium phosphate solution in patients undergoing elective colonoscopy. Aliment Pharmacol Ther. 2006;24:1631-1642. [PMID: 17094774 DOI: 10.1111/j.1365-2036.2006.03167.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
50 Fina D, Franchi L, Caruso R, Peluso I, Naccari GC, Bellinvia S, Testi R, Pallone F, Monteleone G. 5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death. Eur J Cancer 2006;42:2609-16. [PMID: 16914308 DOI: 10.1016/j.ejca.2006.03.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
51 Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
52 Di Fiore F, Lecleire S, Galais M, Rigal O, Vié B, David I, Hamidou H, Paillot B, Jacob J, Michel P. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroentérologie Clinique et Biologique 2006;30:845-51. [DOI: 10.1016/s0399-8320(06)73331-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
53 Jung M. [Mucosectomy as sufficient therapy for early squamous cell]. Chirurg 2005;76:1018-24. [PMID: 16237563 DOI: 10.1007/s00104-005-1106-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Monteleone G, Franchi L, Fina D, Caruso R, Vavassori P, Monteleone I, Calabrese E, Naccari GC, Bellinvia S, Testi R, Pallone F. Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells. Cell Death Differ 2006;13:202-11. [PMID: 16082388 DOI: 10.1038/sj.cdd.4401733] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
55 Michel P, Di Fiore F. [Adjuvant chemotherapy for gastric carcinoma]. Gastroenterol Clin Biol 2006;30:96-101. [PMID: 16514386 DOI: 10.1016/s0399-8320(06)73120-7] [Reference Citation Analysis]
56 Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer. 2005;41:2792-2805. [PMID: 16290133 DOI: 10.1016/j.ejca.2005.09.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
57 Ocker M, Neureiter D, Lueders M, Zopf S, Ganslmayer M, Hahn EG, Herold C, Schuppan D. Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer. Gut 2005;54:1298-308. [PMID: 16099798 DOI: 10.1136/gut.2004.056192] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
58 Sugai T, Habano W, Uesugi N, Jao YF, Nakamura S, Abe K, Takagane A, Terashima M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol. 2004;17:1223-1234. [PMID: 15154009 DOI: 10.1038/sj.bjc.6602533] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]